| Nov 19 |
Biotech: 3 Reasons The Recent Selloff Is A Buying Opportunity For XBI (Upgrade)
|
| Nov 6 |
SA Asks: How will the U.S. election results impact healthcare stocks?
|
| Nov 4 |
Can Equal-Weight ETFs Protect From Extreme Concentration?
|
| Oct 31 |
F/m Guides Emerald Advisers’ ETF Debut
|
| Oct 24 |
XBI: Biotech ETF Is A Must Have
|
| Oct 11 |
Capitulation in biotech is near, as well as a rally – Piper Sandler
|
| Oct 10 |
Biotech and Retail ETFs have the highest implied call return according to Goldman
|
| Sep 27 |
Biotech IPOs return as sector recovers after funding overhang
|
| Sep 17 |
Gold Just Hit a Record High. It Could Be Headed for $3000 Next.
|
| Sep 16 |
XBI Is Breaking Out And Likely To Outperform In The Near Term (Technical Analysis)
|
